Published in Nat Rev Endocrinol on July 15, 2016
Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer. Oncotarget (2017) 0.75
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E. Oncotarget (2017) 0.75
Prospective study of ultraviolet radiation exposure and thyroid cancer risk in the United States. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Knockdown of IQGAP1 inhibits proliferation and epithelial-mesenchymal transition by Wnt/β-catenin pathway in thyroid cancer. Onco Targets Ther (2017) 0.75
Thyroid Radiation Dose to Patients From Diagnostic Radiology Procedures Over Eight Decades: 1930-2010. Health Phys (2017) 0.75
Review of Factors Related to the Thyroid Cancer Epidemic. Int J Endocrinol (2017) 0.75
Less is more: reconsidering the need for regular use of diagnostic whole body radioiodine scintigraphy in the follow-up of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2017) 0.75
Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype. Endocr Relat Cancer (2017) 0.75
Dual control of pituitary thyroid stimulating hormone secretion by thyroxine and triiodothyronine in athyreotic patients. Ther Adv Endocrinol Metab (2017) 0.75
New Evidence on the Association between Prediagnostic Thyroid-Stimulating Hormone Levels and Thyroid Cancer Risk. Cancer Epidemiol Biomarkers Prev (2017) 0.75
MicroRNAs as Biomarkers in Thyroid Carcinoma. Int J Genomics (2017) 0.75
Risk of thyroid cancer among solid organ transplant recipients. Am J Transplant (2017) 0.75
Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA (2014) 36.94
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2006) 12.23
The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum (1953) 10.06
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA (2014) 6.42
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res (1995) 5.72
BRAF mutation in thyroid cancer. Endocr Relat Cancer (2005) 5.65
Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) (2013) 3.69
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol (2016) 3.48
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab (2008) 3.38
Overdiagnosis and overtreatment of prostate cancer. Eur Urol (2014) 3.25
Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res (1997) 3.06
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol (2013) 2.80
Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med (2014) 2.74
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
NCRP Report No. 160, Ionizing Radiation Exposure of the Population of the United States, medical exposure--are we doing less with more, and is there a role for health physicists? Health Phys (2009) 2.56
The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg (2007) 2.36
Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer (2001) 2.36
Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab (2013) 2.34
The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab (2013) 2.17
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control (2008) 2.17
Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg (2014) 2.15
Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid (2012) 2.09
Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) (2005) 2.07
Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest (2009) 1.91
Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg (2010) 1.86
Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery (2013) 1.85
RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology (2006) 1.85
Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol (2009) 1.74
RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Res (2008) 1.67
Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee. J Am Coll Radiol (2014) 1.66
Continued rapid increase in thyroid cancer incidence in california: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiol Biomarkers Prev (2014) 1.66
A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid (2009) 1.62
Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid (2002) 1.51
The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev (2013) 1.42
Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer (2011) 1.34
Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res (1995) 1.33
Increasing thyroid cancer incidence in Lithuania in 1978-2003. BMC Cancer (2006) 1.22
Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase. Thyroid (2006) 1.20
Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev (2010) 1.20
Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control (2012) 1.19
Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation. Int J Cancer (2012) 1.18
Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer (2012) 1.17
Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol) (2011) 1.17
Smoking and thyroid. Clin Endocrinol (Oxf) (2013) 1.17
Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control (2011) 1.14
Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer (2003) 1.13
Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007. Asia Pac J Public Health (2012) 1.13
Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer (2014) 1.13
Thyroid cancer: an epidemic of disease or an epidemic of diagnosis? Int J Cancer (2014) 1.10
Increasing thyroid cancer incidence in Queensland, Australia 1982-2008 - true increase or overdiagnosis? Clin Endocrinol (Oxf) (2015) 1.05
Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf) (2013) 1.02
Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer (1993) 1.02
The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol (2013) 1.00
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. J Clin Oncol (2015) 1.00
Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans. J Clin Endocrinol Metab (2012) 0.99
Modifications in the papillary thyroid cancer gene profile over the last 15 years. J Clin Endocrinol Metab (2012) 0.98
Is there really an increased incidence of thyroid cancer? Curr Opin Endocrinol Diabetes Obes (2014) 0.96
Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res (2013) 0.94
Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev (2015) 0.93
Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Endocrinology (2013) 0.92
Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol (2003) 0.91
Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst (2014) 0.90
Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis. Eur J Epidemiol (2013) 0.90
Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol (2015) 0.90
Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors. Med Pediatr Oncol (1997) 0.89
Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. Thyroid (2013) 0.89
Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab (1997) 0.89
The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery (2014) 0.88
Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms. Obes Rev (2013) 0.86
Thyroid cancer risk and smoking status: a meta-analysis. Cancer Causes Control (2014) 0.86
Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database. Eur J Epidemiol (2007) 0.85
Changing Trends in the Incidence of Thyroid Cancer in the United States. JAMA Otolaryngol Head Neck Surg (2016) 0.85
Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies. Cancer Causes Control (2012) 0.84
Benign and Malignant Thyroid Incidentalomas Are Rare in Routine Clinical Practice: A Review of 97,908 Imaging Studies. Cancer Epidemiol Biomarkers Prev (2015) 0.84
Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res (2015) 0.84
Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series. J Clin Endocrinol Metab (2008) 0.83
Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies. Cancer Causes Control (2015) 0.83
Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival. World J Surg (2016) 0.83
Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management-A Case Report. Thyroid (2015) 0.80
Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies. Int J Cancer (2015) 0.80
Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure. Thyroid (2006) 0.79
Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer (2015) 0.77
Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine (2014) 0.76
Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer (2015) 0.76
Trends of Thyroid Cancer in Israel: 1980-2012. Rambam Maimonides Med J (2016) 0.76
Diabetes, Diabetes Treatment, and Risk of Thyroid Cancer. J Clin Endocrinol Metab (2016) 0.76
Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients. PLoS One (2016) 0.76
Re: Brito et al., overdiagnosis of thyroid cancer and Graves' disease. Thyroid (2014) 0.76
Adolescent and mid-life diet and subsequent risk of thyroid cancer in the NIH-AARP diet and health study. Int J Cancer (2015) 0.76
Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age. Thyroid (2015) 0.75
Observing micopapillary thyroid cancers. Thyroid (2014) 0.75